device

Johnson & Johnson Vision Completes Acquisition of Device Manufacturer TearScience

SANTA ANA, Calif.—Johnson Johnson Vision has completed its previously announced acquisition of TearScience Inc., a medical device manufacturer that focuses on evaluating meibomian gland health and treating Meibomian Gland Dysfunction (MGD), the leading cause of dry eye disease. In an announcement earlier this week, JJ Vision said the transaction represents another step in its strategy to become “a broad-based, global leader in eye health and further expands the company’s leading eye health portfolio.” In addition, JJ Vision noted that the acquisition marks its expansion into dry eye medical device technology and provides “a complementary eye health solution to address an…